CD8A and neoplasm: Several mechanisms explaining decreased immunotherapy effectiveness in the liver have been proposed, including the liver trapping and destroying activated CD8+ T‐cells and expression of anti‐inflammatory cytokines resulting in inhibitory tumor metabolism.27, 28